Thus, HCC mouse models derived from the F1 subtype are responsive to anti-PD-1 (programmed cell death protein 1) therapy, in contrast with mouse models derived from the F2 and F3 subtypes [36]. Here, PDCD1 is linked to hepatocellular carcinoma.